Posts

December 18, 2014

+
5:26 PM | Is synthetic biology sliding down the eugenics slope?
“What will we do with this?” is a question we ask each time a significant new product or technology is developed. In some cases, the question is literal: Lasers were considered a...
+
5:26 PM | Is synthetic biology sliding down the eugenics slope?
“What will we do with this?” is a question we ask each time a significant new product or technology is developed. In some cases, the question is literal: Lasers were considered a...
+
2:36 PM | What’s the Answer? (FANTOM5 promoter atlas)
Biostars is a site for asking, answering and discussing bioinformatics questions and issues. We are members of the community and find it very useful. Often questions and answers arise at Biostars that are germane to our readers (end users of genomics resources). Every Thursday we will be highlighting one of those items or discussions here […]

Forrest A.R.R., Michael Rehli, J. Kenneth Baillie, Michiel J. L. de Hoon, Vanja Haberle, Timo Lassmann, Ivan V. Kulakovskiy, Marina Lizio, Masayoshi Itoh & Robin Andersson & (2014). A promoter-level mammalian expression atlas, Nature, 507 (7493) 462-470. DOI: http://dx.doi.org/10.1038/nature13182

Severin J., Jayson Harshbarger, Hideya Kawaji, Carsten O Daub, Yoshihide Hayashizaki, Nicolas Bertin & Alistair R R Forrest (2014). Interactive visualization and analysis of large-scale sequencing datasets using ZENBU, Nature Biotechnology, 32 (3) 217-219. DOI: http://dx.doi.org/10.1038/nbt.2840

Citation
+
12:56 PM | How to Use the Genetic Code for Passwords
  Need a password for a new device or service? Try the genetic code. Messenger RNA triplets and the amino acids they specify provide nearly endless password possibilities. And it’s timely — the People’s Choice for Science magazine’s Breakthrough of … Continue reading »The post How to Use the Genetic Code for Passwords appeared first on DNA Science Blog.
+
12:16 AM | GCI Health promotes Becky Lauer
She becomes executive VP
+
12:16 AM | Data transparency in Europe
Will 2015 usher in a new era?
+
12:15 AM | Xellia forms scientific advisory board
Will further progress on innovative anti-infectives

December 17, 2014

+
6:45 PM | Blogging for Science Outreach, Blogging for Myself
A few weeks ago, I blogged about a new paper that came out in Public Understanding of Science on science bloggers’ practices, motivations and target audiences. In the paper, Mathieu Ranger and Karen Bultitude interviewed seven authors of popular science blogs. Among their findings, most of the bloggers they interviewed cited personal motivations to blog about science: “The most commonly reported motivation was intrinsic in nature, […]
+
5:00 PM | Of Mice and Men: The Evolution of Cis-Regulatory Elements
DNase Hypersenestive sites (DHSs) are regions within the genome that are susceptible to cleavage by the enzyme DNase I. These regions are susceptible because they lie in uncondensed regions of euchromatin and are readily accessible to the DNase enzyme. In vivo however, these regions are also accessible to regulatory proteins ... The post Of Mice and Men: The Evolution of Cis-Regulatory Elements appeared first on EpiBeat.
+
4:55 PM | First biosimilar Humira launches in India
AbbVie to face competition for world’s biggest-selling drug
+
4:18 PM | Using Laser Treatment to Eliminate Blood-Borne Pathogens
Keeping our blood supply safe is increasingly difficult in the face of newly discovered pathogens that can be transmitted via blood. The tests developed to ensure the blood is free of pathogens like HIV and HBV are based on known pathogens and available screening tests. What about an emerging virus? How can we ensure our […]
+
2:38 PM | Video Tip of the Week: yEd Graph Editor for visualizing pathways and networks
This week’s video tip of the week closes out a series that began last month. I started to explore one gene co-expression tool, which led me to another tool for visualization, and so on. This week’s tool is the final piece that you need to know about if you want to create the kind of […]

Wright D.W., Anton J. Enright & Tom C. Freeman (2014). Visualisation of BioPAX Networks using BioLayout Express3D, F1000Research, DOI: http://dx.doi.org/10.12688/f1000research.5499.1

Smoot M.E., J. Ruscheinski, P.-L. Wang & T. Ideker (2010). Cytoscape 2.8: new features for data integration and network visualization, Bioinformatics, 27 (3) 431-432. DOI: http://dx.doi.org/10.1093/bioinformatics/btq675

Citation
+
1:14 PM | Hundreds of Millions of Euros Awarded to European Scientists
Earlier this week, the European Research Council (ERC), announced that it had awarded 328 early career researchers with €485 million in research grants. The grants were awarded to 38 nationalities, hosted in 180 different institutions throughout Europe. In total, there were 3,273 applications across 3 major disciplines, (life sciences, physical sciences and social sciences and […]
+
12:26 PM | Private sector on rise in England’s NHS, says BMJ
One-third of NHS contracts have gone to private providers since healthcare reforms
+
11:05 AM | UCB's $1.53bn generics sale falls through
Advent and Avista Capita back away from bid to acquire Kremers Urban due to unanticipated conflict in timing
+
10:40 AM | FDA approves Ipsen drug to treat rare tumours
Green light for Somatuline Depot in cancer of the neuroendocrine system
+
10:09 AM | Novartis' acromegaly therapy cleared by FDA
Signifor LAR shows superior efficiency to older treatments
+
9:58 AM | NICE recommends Pradaxa in blood clot indication
Boehringer drug backed to treat and prevent deep vein thrombosis and pulmonary embolism
+
12:15 AM | The use of search enginges in health
The vast majority of health seekers use  search engines as a starting point to gain information on a disease or illness
+
12:15 AM | The use of search engines in health
The vast majority of health seekers use search engines as a starting point to gain information on a disease or illness
+
12:00 AM | FlowMetric Diagnostics names president
Amy Williams has over 25 years of experience in life sciences

December 16, 2014

+
9:53 PM | Sidney Crosby, the NHL, and mumps–separating myth from science
Yesterday, I posted an article about the recent mumps outbreak in the National Hockey League, which has hit 13 players (there’s no official number, it varies depending on the source) including one of top stars of the league, Sidney Crosby of the Pittsburgh Penguins. A fourteenth player, also on the Pittsburgh team, may also have the virus, depending on the test […]Continue reading «Sidney Crosby, the NHL, and mumps–separating myth from […]
+
6:59 PM | Why Imagination and Creativity are Essential to Science
Most people think that creativity belongs to art while science deals with the realm of fact. However, Professor Alan Schwabacher argues that both creativity and imagination are just as important to the sciences as they are to the arts. Watch the talk below and let us know if you agree with Prof. Schwabacher’s thesis. Tweet […]
+
4:27 PM | EMA: Lack of evidence for Ebola treatments
Not enough data to draw conclusions on effectiveness of experimental drugs
+
12:10 PM | Injectable 3D vaccines to target cancer and infectious diseases
Cancer cells can be stealth like in their ability to evade attack from the immune system. This allows tumours to flourish and spread. The implantation of material into the body to target an immune response offers a promising alternative to the injection of cells manipulated ex vivo, but it involves a surgical procedure. Now aRead More
+
10:59 AM | Patent cliff losses set to cost pharma $69bn by 2019
Central nervous system treatments particularly at risk, says GlobalData
+
10:59 AM | Patent cliff losses set to cost pharma $65bn by 2019
Lilly, AZ and Otsuka to be hit hard, says GlobalData
+
10:50 AM | NICE backs Pfizer drug in kidney cancer
Inlyta near end of two-year struggle for recommendation
+
10:48 AM | Germany's IQWiG delivers bad news for Bayer’s Eylea
Says drug provides no additional benefit over Novartis’ rival Lucentis in eye condition
+
10:32 AM | Roche and Exelixis file melanoma duo in US
Combination of cobimetinib and Zelboraf improved progression-free survival by 9.9 months
123456789
317 Results